Accused “Fraudster” Heads Two Journals

A Russian researcher suspected of multiple counts of fakery is chief editor of two scientific publications.

Written byKerry Grens
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

FLICKR, JOHN MARTINEZ PAVLIGADmitry Kuznetsov, a Russian biochemist whose published work has been repeatedly alleged to be fraudulent, is now the chief editor of two science journals. The appointments are raising questions about the scientific integrity of the publications.

The accusations against Kuznetsov, if true, amount to “one of the worst fraud records in the history of science,” said Dan Larhammar, a professor at Uppsala University in Sweden who has written about problems in Kuznetsov's work. “That should be a major concern to” the publisher that recruited Kuznetsov as editor-in-chief, he said.

Kuznetsov (whose name is also spelled Kouznetsov, Kouznetsoff, Kuesnetzov, Kznetsov, and Kuznetcef) is currently a Leading Research Fellow at the N. N. Semenov Institute for Chemical Physics in Moscow. He is also the chief editor of two journals published by open-access publisher ScienceDomain: the British Journal of Medicine and Medical Research and the International Research Journal of Pure and Applied Chemistry. Both journals launched in 2011.

Michael Coey, a professor at Trinity ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies